Physician profile
Issam E Cheikh
NPI 1639132848
$684.61
in general payments reported to CMS, 2019-2025
21 companies · $2.20 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $295 · 2020: $64.68 · 2021: $130 · 2022: $44.83 · 2023: $122 · 2024: $26.57 · 2025: $2.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $148 · Education: $2.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $148.40 |
| Education | $2.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $98.53 | 2019-2023 | Jardiance |
| Sanofi-Aventis U.S. LLC | $87.45 | 2019-2023 | |
| Lilly USA, LLC | $78.81 | 2019-2022 | |
| Novo Nordisk INC | $55.54 | 2019 | |
| Xeris Pharmaceuticals, INC. | $41.28 | 2021-2023 | Recorlev |
| Novartis Pharmaceuticals Corporation | $31.29 | 2023 | |
| Amgen INC. | $27.38 | 2019 | |
| Corcept Therapeutics | $26.57 | 2024 | Korlym |
| Acerus Pharmaceuticals Corporation | $25.52 | 2021 | |
| Abbott Laboratories | $23.93 | 2019 | |
| Valeritas, INC. | $22.59 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $20.23 | 2021 | |
| Cequr Corporation | $20.00 | 2023 | Cequr Simplicity |
| Ipsen Biopharmaceuticals, INC | $19.12 | 2019 | |
| Shire North American Group INC | $19.07 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $17.94 | 2021 | |
| Abbvie INC. | $16.90 | 2021 | |
| Janssen Pharmaceuticals, INC | $15.76 | 2019 | |
| Medtronic Minimed, INC. | $15.52 | 2020 | |
| Companion Medical, INC. | $12.60 | 2019 | |
| Travere Therapeutics, INC. | $8.58 | 2020-2025 | Thiola |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Issam Cheikh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.